Published in Cell Cycle on June 30, 2008
Two different specific JNK activators are required to trigger apoptosis or compensatory proliferation in response to Rbf1 in Drosophila. Cell Cycle (2016) 1.00
Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis. Sci Rep (2013) 0.83
Loss of E2F1 Extends Survival and Accelerates Oral Tumor Growth in HPV-Positive Mice. Cancers (Basel) (2015) 0.75
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
Effects of an Rb mutation in the mouse. Nature (1992) 11.06
The RB and p53 pathways in cancer. Cancer Cell (2002) 8.02
Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol (2002) 7.64
E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell (1996) 5.26
Tumor induction and tissue atrophy in mice lacking E2F-1. Cell (1996) 4.80
The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer (2002) 4.48
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev (2003) 4.40
The E2F1-3 transcription factors are essential for cellular proliferation. Nature (2001) 4.37
Does aneuploidy cause cancer? Curr Opin Cell Biol (2006) 3.89
E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev (1998) 3.48
Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev (2001) 3.41
Chk2 activates E2F-1 in response to DNA damage. Nat Cell Biol (2003) 3.12
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol (2003) 3.05
Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell (1998) 3.05
Mechanisms of sarcoma development. Nat Rev Cancer (2003) 2.78
Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet (1994) 2.73
The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev (1996) 2.58
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A (1997) 2.31
Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell (2003) 2.20
Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20
Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Curr Mol Med (2006) 2.01
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev (1997) 1.85
Regulation of E2F1 by BRCT domain-containing protein TopBP1. Mol Cell Biol (2003) 1.84
pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell (2003) 1.77
Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev (1997) 1.59
E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell (2002) 1.59
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop. Mol Cell Biol (2007) 1.55
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage. EMBO J (2007) 1.52
Re-evaluating cell-cycle regulation by E2Fs. Cell (2006) 1.46
Reduction in rate of occurrence of age related lesions in dietary restricted laboratory mice. Growth Dev Aging (1991) 1.45
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res (2004) 1.33
Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol (2002) 1.22
Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell (2005) 1.17
Endogenous E2F-1 promotes timely G0 exit of resting mouse embryo fibroblasts. Proc Natl Acad Sci U S A (1998) 1.16
Probing p53 biological functions through the use of genetically engineered mouse models. Mutat Res (2005) 1.14
Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat Genet (2002) 1.13
Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J (2007) 0.98
Mechanisms of carcinogenesis and the mutant mouse. Curr Opin Genet Dev (1996) 0.92
Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1. Nat Cell Biol (2004) 0.85
p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98
Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97
p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell (2012) 4.11
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res (2008) 3.58
The MDM2-p53 interaction. Mol Cancer Res (2003) 3.43
The mitochondrial p53 pathway. Biochim Biophys Acta (2008) 2.98
Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J (2007) 2.62
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50
DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med (2002) 2.48
While p73 is essential, p63 is completely dispensable for the development of the central nervous system. Cell Cycle (2011) 2.31
p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res (2008) 2.27
A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol (2002) 2.27
Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res (2006) 2.17
The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Cell Cycle (2009) 2.00
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem (2006) 1.94
Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res (2011) 1.77
A tautomerase-null macrophage migration-inhibitory factor (MIF) gene knock-in mouse model reveals that protein interactions and not enzymatic activity mediate MIF-dependent growth regulation. Mol Cell Biol (2009) 1.43
p73 suppresses polyploidy and aneuploidy in the absence of functional p53. Mol Cell (2007) 1.41
Links between mutant p53 and genomic instability. J Cell Biochem (2012) 1.41
Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res (2004) 1.36
Nuclear degradation of p53 occurs during down-regulation of the p53 response after DNA damage. FASEB J (2002) 1.34
deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo. Mol Cell Biol (2003) 1.33
Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res (2005) 1.33
Direct reprogramming by oncogenic Ras and Myc. Proc Natl Acad Sci U S A (2013) 1.26
The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle (2007) 1.25
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. J Exp Med (2012) 1.23
Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med (2007) 1.19
Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway. Mol Cell (2005) 1.17
Stress-induced p53 runs a transcription-independent death program. Biochem Biophys Res Commun (2005) 1.13
BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J Biol Chem (2009) 1.12
Detection of mitochondrial localization of p53. Methods Mol Biol (2003) 1.11
Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Clin Cancer Res (2005) 1.05
Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage. FASEB J (2003) 1.04
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci U S A (2014) 1.03
Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci U S A (2011) 1.03
Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle (2004) 1.01
Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J (2007) 0.98
A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model. Cell Cycle (2008) 0.97
Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle (2007) 0.96
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div (2007) 0.96
Mitochondrially targeted wild-type p53 induces apoptosis in a solid human tumor xenograft model. Cell Cycle (2008) 0.96
Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA. Nucleic Acids Res (2004) 0.94
Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer. Eur J Cancer (2007) 0.94
p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy. Mutat Res (2009) 0.93
Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett (2005) 0.93
Role of the p53 family in stabilizing the genome and preventing polyploidization. Adv Exp Med Biol (2010) 0.91
Inhibition of topoisomerase IIα: novel function of wedelolactone. Cancer Lett (2011) 0.90
Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice. J Clin Invest (2010) 0.90
Brdm2 - an aberrant hypomorphic p63 allele. Cell Death Differ (2010) 0.90
Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F₁F0-ATP synthase. Cell Cycle (2013) 0.89
TAp73 is essential for germ cell adhesion and maturation in testis. J Cell Biol (2014) 0.86
Identification of p53 in mitochondria. Methods Mol Biol (2013) 0.85
Targeting the heat shock protein 90: a rational way to inhibit macrophage migration inhibitory factor function in cancer. Curr Opin Oncol (2014) 0.85
Role of p53 family members p73 and p63 in human hematological malignancies. Leuk Lymphoma (2012) 0.84
Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers. Int J Oncol (2006) 0.82
Analysis of nuclear and cytoplasmic degradation of p53 in cells after stress. Methods Mol Biol (2003) 0.81
Targeted deletion of p73 in mice reveals its role in T cell development and lymphomagenesis. PLoS One (2009) 0.81
Cortical hypoplasia and ventriculomegaly of p73-deficient mice: Developmental and adult analysis. J Comp Neurol (2014) 0.80
Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene (2003) 0.80
Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP. Methods Mol Biol (2003) 0.80
Mutational analysis of p53 in human tumors: immunocytochemistry. Methods Mol Biol (2003) 0.79
HSP90 inhibitor antagonizing MIF: The specifics of pleiotropic cancer drug candidates. Oncoimmunology (2012) 0.78
p63 and canonical Wnt signaling. Cell Cycle (2010) 0.77
Generation of p53-deficient induced pluripotent stem cells from mouse embryo fibroblasts. Methods Mol Biol (2013) 0.77
p63 regulation by microRNAs. Cell Cycle (2009) 0.76
Rational design of DNA sequences for nanotechnology, microarrays and molecular computers using Eulerian graphs. Nucleic Acids Res (2004) 0.76
Direct reprogramming en route to neoplastic transformation. Cell Cycle (2013) 0.75
p53 further extends its reach. Oncoimmunology (2013) 0.75
Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks. Cell (2016) 0.75